|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-4-22
|
|
pubmed:abstractText |
To evaluate the relationship between bone mass and risk of breast cancer and to determine the effect of raloxifene therapy on breast cancer incidence in women categorized by bone mass into low bone mass and osteoporosis subgroups.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
807-13
|
|
pubmed:meshHeading |
pubmed-meshheading:18254988-Aged,
pubmed-meshheading:18254988-Bone Density,
pubmed-meshheading:18254988-Bone Density Conservation Agents,
pubmed-meshheading:18254988-Breast Neoplasms,
pubmed-meshheading:18254988-Carcinoma, Ductal, Breast,
pubmed-meshheading:18254988-Female,
pubmed-meshheading:18254988-Femur,
pubmed-meshheading:18254988-Follow-Up Studies,
pubmed-meshheading:18254988-Humans,
pubmed-meshheading:18254988-Incidence,
pubmed-meshheading:18254988-Lumbar Vertebrae,
pubmed-meshheading:18254988-Middle Aged,
pubmed-meshheading:18254988-Osteoporosis, Postmenopausal,
pubmed-meshheading:18254988-Raloxifene,
pubmed-meshheading:18254988-Receptors, Estrogen,
pubmed-meshheading:18254988-Risk Factors,
pubmed-meshheading:18254988-Selective Estrogen Receptor Modulators,
pubmed-meshheading:18254988-United States
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
|
|
pubmed:affiliation |
Ochsner Clinic Foundation, New Orleans, LA 70121, USA. ABURSHELL@ochsner.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
